Viridian Therapeutics Statistics
Total Valuation
VRDN has a market cap or net worth of $2.10 billion. The enterprise value is $1.40 billion.
| Market Cap | 2.10B |
| Enterprise Value | 1.40B |
Important Dates
The next estimated earnings date is Wednesday, August 5, 2026, before market open.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VRDN has 110.43 million shares outstanding. The number of shares has increased by 23.41% in one year.
| Current Share Class | 110.43M |
| Shares Outstanding | 110.43M |
| Shares Change (YoY) | +23.41% |
| Shares Change (QoQ) | +8.30% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 104.62% |
| Float | 104.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 29.68 |
| Forward PS | 29.80 |
| PB Ratio | 3.88 |
| P/TBV Ratio | 4.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 19.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.15, with a Debt / Equity ratio of 0.08.
| Current Ratio | 15.15 |
| Quick Ratio | 14.71 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -49.07 |
Financial Efficiency
Return on equity (ROE) is -58.14% and return on invested capital (ROIC) is -36.61%.
| Return on Equity (ROE) | -58.14% |
| Return on Assets (ROA) | -33.25% |
| Return on Invested Capital (ROIC) | -36.61% |
| Return on Capital Employed (ROCE) | -52.32% |
| Weighted Average Cost of Capital (WACC) | 9.23% |
| Revenue Per Employee | $281,421 |
| Profits Per Employee | -$1.20M |
| Employee Count | 252 |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.20% in the last 52 weeks. The beta is 0.90, so VRDN's price volatility has been lower than the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | +11.20% |
| 50-Day Moving Average | 17.39 |
| 200-Day Moving Average | 24.12 |
| Relative Strength Index (RSI) | 56.15 |
| Average Volume (20 Days) | 2,549,733 |
Short Selling Information
The latest short interest is 17.34 million, so 15.71% of the outstanding shares have been sold short.
| Short Interest | 17.34M |
| Short Previous Month | 15.02M |
| Short % of Shares Out | 15.71% |
| Short % of Float | 16.56% |
| Short Ratio (days to cover) | 7.56 |
Income Statement
In the last 12 months, VRDN had revenue of $70.92 million and -$303.27 million in losses. Loss per share was -$3.37.
| Revenue | 70.92M |
| Gross Profit | -268.72M |
| Operating Income | -385.70M |
| Pretax Income | -360.59M |
| Net Income | -303.27M |
| EBITDA | -385.23M |
| EBIT | -385.70M |
| Loss Per Share | -$3.37 |
Balance Sheet
The company has $762.18 million in cash and $53.35 million in debt, with a net cash position of $708.83 million or $6.42 per share.
| Cash & Cash Equivalents | 762.18M |
| Total Debt | 53.35M |
| Net Cash | 708.83M |
| Net Cash Per Share | $6.42 |
| Equity (Book Value) | 636.01M |
| Book Value Per Share | 4.92 |
| Working Capital | 732.94M |
Cash Flow
In the last 12 months, operating cash flow was -$303.39 million and capital expenditures -$432,000, giving a free cash flow of -$303.82 million.
| Operating Cash Flow | -303.39M |
| Capital Expenditures | -432,000 |
| Depreciation & Amortization | 464,000 |
| Net Borrowing | 28.88M |
| Free Cash Flow | -303.82M |
| FCF Per Share | -$2.75 |
Margins
| Gross Margin | n/a |
| Operating Margin | -543.86% |
| Pretax Margin | -508.46% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VRDN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.41% |
| Shareholder Yield | -23.41% |
| Earnings Yield | -14.41% |
| FCF Yield | -14.44% |
Analyst Forecast
The average price target for VRDN is $36.13, which is 89.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $36.13 |
| Price Target Difference | 89.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 102.11% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 13, 2020. It was a reverse split with a ratio of 1:15.
| Last Split Date | Nov 13, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
VRDN has an Altman Z-Score of 4.88 and a Piotroski F-Score of 1.
| Altman Z-Score | 4.88 |
| Piotroski F-Score | 1 |